Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice

Experimental Hematology

Volumn 31, Issue 6, 2003, Pages 521-527

  TeKippe, Michael ^a   Harrison, David E ^a   Chen, Jichun ^b,c  

^a JACKSON LABORATORY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CD11B ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL PROTEIN; PROTEIN LIN; PROTEIN P53; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; BLOOD CELL; BLOOD CELL COUNT; BONE MARROW CELL; CELL ACTIVITY; CELL COMPOSITION; CELL SURVIVAL; CELL TYPE; COLONY FORMING UNIT S; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

MURINAE;

EID: 0037711685     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00072-9     Document Type: Conference Paper

References (36)

1. Chen J., Astle C.M., Harrison D.E. Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol. 27:1999;928-935.
2. Harrison D.E., Jordan C.T., Zhong R.K., Astle C.M. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol. 21:(2):1993;206-219.
3. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Ann Rev Cell Dev Biol. 11:1995;35-71.
4. Young N.S. Aplastic anemia. Kassirer J.P. Current Therapy in Internal Medicine. 1991;804-808 Decker, B.C, Philadelphia.
5. Young N.S. Acquired aplastic anemia. JAMA. 282:1999;271-278.
6. The Staff of The Jackson Laboratory. Handbook on Genetically Standardized JAX Mice. 1997;The Jackson Laboratory, Bar Harbor.
7. Donehower L.A., Harvey M., Slagle B.L., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
8. Jacks T., Remington L., Williams B.O., et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol. 4:1994;1-7.
9. Giese H., Snyder W.K., van Oostrom C., van Steeg H., Dolle M.E.T., Vijg J. Age-related mutation accumulation at a lacZ reporter locus in normal and tumor tissues of Trp53-deficient mice. Mutation Res. 514:2002;153-163.
10. Chang P.Y., Kanazawa N., Lutze-Mann L., Winegar R.A. p53 deficiency alters the yield and spectrum of radiation-induced lacZ mutants in the brain of transgenic mice. Mutagenesis. 16:2000;7-15.
11. cip1/waf1. Science. 287:2000;1804-1808.
12. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 29:2001;418-425.
13. kip1. Nat Med. 6:2000;1235-1240.
14. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 92:1995;10688-10692.
15. low/negative hematopoietic stem cell. Science. 273:(5272):1996;242-245.
16. Chen J., Astle C.M., Harrison D.E. Genetic regulation of primitive hematopoietic stem cell senescence. Exp Hematol. 28:2000;442-450.
17. Chen J., Harrison D.E. Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood. Blood. 99:2002;561-566.
18. Harrison D.E., Astle C.M., Stone M. Numbers and functions of transplantable primitive immunohematopoietic stem cells. Effects of age. J Immunol. 142:(11):1989;3833-3840.
19. SAS Institute Inc. JMP Statistics and Graphics Guide, Version 3. 1998;SAS Institute, Cary, NC.
20. Jordan S.A., Speed R.M., Brenex F., Jackson I.J. Deficiency of Trp53 rescues the male fertility defects of KitW-v mice but has no effect on the survival of melanocytes and mast cells. Devel Biol. 215:1999;78-90.
21. Shounan Y., Dolnikov A., MacKenzie K.L., Miller M., Chan Y.Y., Symonds G. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia. 10:1996;1619-1628.
22. Tsukada T., Tomooka Y., Takai S., et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
23. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
24. Xu X., Qiao W., Linke S.P., et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet. 28:2001;266-271.
25. Hirabayashi Y., Matsuda M., Matumura T., et al. The p53-deficient hemopoietic stem cells: their resistance to radiation-apoptosis, but lasted transiently. Leukemia. 11:1997;489-492.
26. Wlodarski P., Wasik M., Ratajczak M.Z., et al. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood. 91:1998;2998-3006.
27. Spangrude G.J., Brooks D.M., Tumas D.B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood. 85:(4):1995;1006-1016.
28. Chen J., Astle C.M., Harrison D.E. Hematopoietic stem cell functional failure in interleukin-2-deficient mice. J Hematother Stem Cell Res. 11:(6):2002;905-912.
29. + T cells. Cell. 71:1992;1205-1214.
30. De Togni P., Goellner J., Ruddle N.H., et al. Abnormal development of lymphoid organs in mice deficient in lymphotoxin. Science. 264:1994;703-707.
31. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
32. Chen J., Astle C.M., Muller-Sieburg C.E., Harrison D.E. Primitive hemopoietic stem cell function in vivo is uniquely high in the CXB-12 mouse strain. Blood. 96:2000;4124-4131.
33. de Haan G., Szilvassy S.J., Meyerrose T.E., Dontje B., Grimes B., Van Zant G. Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers. Blood. 96:(4):2000;1374-1379.
34. Lotem J., Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood. 82:1993;1092-1096.
35. Mahdi T., Alcalay D., Brizard A., et al. Role of p53 and RB on in vitro growth of normal umbilical cord blood cells. Exp Hematol. 24:1996;702-712.
36. Tyner S.D., Venkatachalam S., Choi J., et al. P53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.